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Origin recognition complex 2 (ORC2), a subunit of the
ORC, is essential for DNA replication initiation in eu-
karyotic cells. In addition to a role in DNA replication
initiation at theG1/S phase, ORC2 has been shown to
localize to the centromere during the G2/M phase.
Here, we show that ORC2 is modified by small ubiq-
uitin-like modifier 2 (SUMO2), but not SUMO1, at the
G2/M phase of the cell cycle. SUMO2-modification of
ORC2 is important for the recruitment of KDM5A
in order to convert H3K4me3 toH3K4me2, a ‘‘permis-
sive’’ histone marker for a-satellite transcription at
the centromere. Persistent expression of SUMO-
less ORC2 led to reduced a-satellite transcription
and impaired pericentric heterochromatin silencing,
which resulted in re-replication of heterochromatin
DNA. DNA re-replication eventually activated the
DNA damage response, causing the bypass of
mitosis and the formation of polyploid cells. Thus,
ORC2 sustains genomic stability by recruiting
KDM5A to maintain centromere histone methylation
in order to prevent DNA re-replication.
INTRODUCTION
The origin recognition complex (ORC), which consists of six sub-
units, is essential for DNA replication initiation in eukaryotic cells
(Bell and Dutta, 2002). In addition to DNA replication initiation at
the G1/S phase, ORC2 and ORC6 also play roles in sister chro-
matid cohesion, heterochromatin silencing, and cytokinesis at
the G2/M phase (Prasanth et al., 2002, 2004, 2010; Shimada
and Gasser, 2007). When a cell exits G1/S, ORC2 gradually dis-
sociates fromDNA replication origins and localizes to the centro-
meric region at the G2/M phase (Craig et al., 2003; Lee et al.,
2012; Prasanth et al., 2004). ORC2 also binds to the repressiveThis is an open access article under the CC BY-Nchromatin marks H3K9me3 and H3K27me3 and, to a lesser
extent, to the active chromatin modification H3K4me3 (Bartke
et al., 2010; Kan et al., 2008), suggesting a role in chromatin
plasticity.
The centromere plays an essential role in chromosome
segregation during mitosis. Centromeres consist of repeated
DNA arrays called a-satellite DNA, on which the kinetochore
is assembled (Wevrick and Willard, 1989). Non-coding RNA
transcribed from these a-satellite repeats is important in main-
taining constitutively silenced pericentric heterochromatin that
is critical to ensuring accuracy of chromatin segregation at
the G2/M phase (Fukagawa et al., 2004; Reinhart and Bartel,
2002; Wong et al., 2007). Aberrant expression of a-satellite
non-coding RNA alters heterochromatin silencing and causes
disorder of chromosome segregation (Ting et al., 2011). In
higher eukaryotic cells, the centromere core domain (CEN chro-
matin) histone H3 nucleosomes exhibit a distinct modification
pattern, which separates them from flanking pericentric hetero-
chromatin characterized by di- and tri-methylated H3K9 (Sulli-
van and Karpen, 2004). H3K4me2 is a ‘‘permissive’’ chromatin
histone marker for a-satellite transcription at centromere (Berg-
mann et al., 2011; Sullivan and Karpen, 2004). Misregulation of
centromeric chromatin H3 methylation and a-satellite transcrip-
tion can lead to genome instability and cancer (Bergmann et al.,
2011; Ting et al., 2011).
KDM5A, a histone H3 lysine 4 demethylase, was initially
identified as a pRb binding protein (Defeo-Jones et al., 1991).
KDM5A suppresses gene expression by removing di- or tri-
methylation of H3K4 at gene promoters (Christensen et al.,
2007; Klose et al., 2007). In cancer cells, KDM5A behaves as
an oncogene or a tumor suppressor depending upon the cellular
context. KDM5A expression is progressively decreased in
advanced and metastatic melanomas and glioblastomas in vivo
with intratumoral heterogeneity (Roesch et al., 2005). High
expression of KDM5A in breast cancer is often associated with
a better prognosis (Paolicchi et al., 2013). These studies suggest
that KDM5A may contribute to uncontrolled growth in malignant
tumors.Cell Reports 15, 147–157, April 5, 2016 ª2016 The Authors 147
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Cell Cycle-Regulated SUMOylation
of ORC2
(A) U2OS cells were double thymidine blocked
(Thy) or treated with mimosine (Mimo) or nocoda-
zole (Noc) for 24 hr. The cells were fractionated and
chromatin was subjected to immunoprecipitation
with the ORC2 antibody. The immunoprecipitates
were blotted with the ORC2, SUMO1, or SUMO2
antibody.
(B) The in vitro SUMOylation assay was performed
with GST-ORC2.
(C) PIASy enhanced level of SUMOylation of ORC2.
The U2OS cells were transfected with indicated
plasmids and Talon beads pull-down was per-
formed after 24 hr treatment of Noc and pre-
cipitates were blotted with anti-FLAG antibody.
(D) Mapping of ORC2 SUMOylation sites. The
U2OS cells were transfected with FLAG-ORC2wt,
FLAG-ORC2 (K36R), FLAG-ORC2 (K51R), or
FLAG-ORC2 (K36 and 51R) with or without His-
SUMO2. The Talon beads pull-down was per-
formed after 24 hr treatment of Noc and pre-
cipitates were blotted with anti-FLAG antibody.
(E) U2OS cells were released into fresh media for
the indicated times after 24 hr treatment with
mimosine (Mimo). The cells were fractionated and
chromatin was subjected to immunoprecipitation
with the ORC2 antibody. The immunoprecipitates
were blotted with the ORC2 or SUMO2 antibody.
(F) U2OS cells were released into fresh media
for the indicated times after 24 hr treatment with
nocodazole (Noc). The cells were fractionated and
chromatin was subjected to immunoprecipitation
with the ORC2 antibody. The immunoprecipitates
were blotted with the ORC2 or SUMO2 antibody.
See also Figure S1.Most small ubiquitin-like modifier (SUMO) targets are nuclear
and function in different biological processes, including hypoxic
response, epigenetic regulation, and homologous recombina-
tion (Cheng et al., 2007; Dou et al., 2010; Hay, 2005; Kang
et al., 2010; Yeh, 2009). Recently, SUMOylation has emerged
as an important regulator ensuring accurate chromosome
condensation and segregation at the G2/M phase (Dasso,
2008; Watts, 2007). Numerous centromere and kinetochore
proteins have been identified as SUMO targets. For instance,
SUMOylation of topoisomerase 2a is essential for correct chro-
mosome segregation (Dawlaty et al., 2008); CENP-E modifica-
tion and binding by SUMO2/3 is critical for cells to progress
through mitosis (Zhang et al., 2008). However, the precise func-
tion of SUMOylation in other mitotic targets is unclear (Denison
et al., 2005).
Here, we show that SUMOylation of ORC2 during the G2/M
phase is important for maintaining normal centromeric histone
H3 methylation to prevent heterochromatin re-replication.
SUMOylation deficiency reduces ORC2 recruitment of KDM5A
to centromeres, causing decondensation of pericentric hetero-
chromatin and DNA re-replication. These alterations eventually
lead to abnormal mitosis and formation of polyploidy. Our find-
ings reveal a crucial role of ORC2 SUMOylation in preventing
DNA re-replication and maintenance of normal cell cycle transi-
tion at the G2/M phase.148 Cell Reports 15, 147–157, April 5, 2016RESULTS
ORC2 Is Modified by SUMO2 in the G2/M Phase of the
Cell Cycle
A 100 kDa band was detected by anti-ORC2 antibody in addition
to ORC2 (80 kDa) in U2OS cells arrested at the G2/M phase (Fig-
ure S1A). This band could be blotted by anti-SUMO2, but not by
anti-SUMO1 antibody (Figure 1A). To confirm that ORC2 can be
SUMOylated, we used an in vitro SUMOylation assay to demon-
strate that ORC2 could be modified by SUMO2, but not gluta-
thione S-transferase (GST) alone (Figures 1B and S1B). Overex-
pression of PIASy, a SUMOE3 ligase, dramatically increased the
level of SUMOylation of ORC2 (Figure 1C). Furthermore, we used
a GPS-SUMO program to predict possible SUMOylation sites
and mapped K36 and K51 as the major SUMO acceptor sites
using site-directed mutagenesis (Figure 1D). Mutation of these
two lysine residues into arginine completely abolished ORC2
SUMOylation.
Since SUMO2-conjugated ORC2 appears only in nocoda-
zole-blocked cells, but not in mimosine- or thymidine-blocked
cells, SUMOylation of ORC2 most likely occurs in the G2/M
phase (Figures 1A and S1A). When cells were released from
mimosine-induced late G1 arrest, SUMO2-conjugated ORC2
appeared 18 to 22 hr later when cells entered the G2/M phase
(Figures 1E and S1C). When U2OS cells arrested at the G2/M
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Figure 2. A Defect of ORC2 SUMOylation
Leads to the Temporary G2 Arrest and
Bypass of Mitosis
(A) Cell lysates from asynchronous U2OS cells
stably transfected with empty vector (EV), ORC2wt
cells, or SUMOylation mutant FLAG-ORC2 (K36
and 51R) (ORC2mut cells) were immunoblotted
with the anti-FLAG or anti-ORC2 antibody.
(B) Cell cycle profiles of ORC2wt cells or ORC2mut
cells are shown.
(C) Cell lysates from asynchronous ORC2wt cells
and ORC2mut cells were subjected to immuno-
blotting with the indicated antibodies.
(D) ORC2wt cells and ORC2mut cells were treated
with nocodazole for 24 hr, and cell lysates were
subjected to immunoblotting with the indicated
antibodies.
(E) ORC2wt cells and ORC2mut cells were treated
with mimosine (Mimo) for 24 hr and released into
fresh media for the indicated times. The cell lysate
was collected for western blot analysis with the
indicated antibodies.
(F) ORC2wt and ORC2mut cells were treated with
nocodazole for 15, 24, 36, or 48 hr. The cells without
nocodazole treatment were used as control. FACS
was performed to show cell cycle profiles.
See also Figure S2.phase were released into fresh media, SUMO2-conjugated
ORC2 disappeared in 2 hr when cells entered early G1 phase
(Figures 1F and S1D). These results showed that ORC2 was
dynamically modified by SUMO2 at the G2/M phase of the
cell cycle.
A Defect in ORC2 SUMOylation Leads to Temporary G2
Phase Arrest and Bypass of Mitosis
To study the function of SUMO2 modification of ORC2, we
generated U2OS cells stably expressing FLAG-tagged wild-
type ORC2 (ORC2wt cells) or SUMO-less ORC2 (K36 and
51R) (ORC2mut cells) (Figure 2A). Consistent with a previous
report (Radichev et al., 2006), exogenous expression of FLAG-
ORC2 completely suppresses the expression of endogenous
ORC2 in U2OS cells (Figure 2A). ORC2wt cells showed no sig-
nificant differences in the cell cycle profiles compared to cells
transfected with empty vector (Figure 2B). However, the cell cy-
cle profile of ORC2mut cells showed enrichment of cells with
DNA content R4C (Figure 2B). Further transfection of ORC2
siRNA produced the same cell cycle profile (Figure S2A). Stable
expressing of ORC2mut cells (K36 and 51R) in three other can-
cer cell lines (HCT116, SW480, and Soas2) also produced thesimilar cell cycle defect seen in the
U2OS cells (Figure S2B). To simplify the
study, we used U2OS cells (ORC2wt
and ORC2mut cells) for subsequent
experiments. Expression of the G2/M
markers cyclin A and cyclin B was
markedly decreased, and CDC25c phos-
phorylation was significantly increased
in ORC2mut cells (Figure 2C). H3Ser10phosphorylation, a mitotic marker, was much lower in the
ORC2mut cells relative to ORC2wt cells (Figures 2D and 2E).
Furthermore, nocodazole treatment for different times indicated
that ORC2mut cells bypassed M phase, as shown by formation
of polyploid cells, low level of phosphorylation of H3Ser10, and
reduction of mitotic cell population (Figures 2F, S2C, and S2D).
These results suggest that cells were temporally arrested at the
G2 phase of the cell cycle and then bypassed mitosis when
ORC2 cannot be modified by SUMO2.
Perturbation of SUMOylation on ORC2 Results in
Polyploidy
ORC2mut cells proliferated much slower than ORC2wt cells due
to the G2 arrest (Figure S3A). However, after prolonged arrest,
ORC2mut cells either bypassed mitosis and progressed into
the next cell cycle as previously reported (Davoli et al., 2010)
or underwent aberrant mitosis. Metaphase chromosome spread
showed that 74.2% of ORC2mut cells were tetraploidy (Fig-
ure 3A). In contrast, almost no tetraploidy were detected in
ORC2wt cells. In addition, the percentage of chromosome
break and chromosome fusion was much higher in ORC2mut
than in ORC2wt cells (Figure 3A). Moreover, 26% of ORC2mutCell Reports 15, 147–157, April 5, 2016 149
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Figure 3. Alterations of Centromeric Histone
H3 Methylation in ORC2 SUMOylaton
Mutant—K36 and 51R—Cells
(A) Typical image of the metaphase chromosome
spread of ORC2wt and ORC2mut cells is shown
(left). The results of metaphase chromosome
spread of ORC2wt and ORC2mut cells are shown
(right). The percentage of cells with mitotic defects
and chromosome abnormality is shown, and the
tetraploid cells in each cell line were counted
(ORC2wt, n = 28 and ORC2mut, n = 31).
(B) ORC2mut cells with 2C DNA content stably
expressing GFP-H2B showed a chromosome
string at telophase.
(C) Polyploid ORC2mut cells stably expressing
GFP-H2B underwent abnormal mitosis. The scale
bar represents 10 mM.
(D) ORC2wt and ORC2mut cells were treated with
mimosine for 24 hr and released into fresh media
for the indicated times. The cell cycle profiles
at each time point were analyzed using flow
cytometry.
See also Figure S3.cells had abnormal mitosis, which may lead to the mitotic catas-
trophe (Figures 3A and S3B). To confirm this, we transfected
chromatin marker GFP-H2B into ORC2wt and ORC2mut
cells and demonstrated abnormal chromosome segregations
including chromosome bridge at anaphase and chromosome
string at telophase in ORC2mut cells (Figures 3B and S3C).
ORC2mut cells often exhibit large nuclei with more than two
centrosomes as shown by the pericentrin staining (Figure 3C).
Interestingly, some ORC2mut cells with large nuclei went
through a mitotic cycle with two centrosomes (Figure 3C), which
might be due to silencing of extra centrosomes or by clustering
of multiple centrosomes into two spindle poles (Kwon et al.,
2008). We further analyzed the cell cycle profiles of ORC2wt
and ORC2mut cells by flow cytometry. Once the cells were
released from mimosine induced late-G1 arrest, ORC2wt cells
progressed normally into S phase, G2/M phase, and returned
to G1 phases 24–36 hr after release. However, most ORC2mut
cells were arrested at the G2/M phase between 24–36 hr after
release (Figure 3D). Importantly, ORC2mut cells with 4C DNA
content initiated DNA replication again after prolonged G2 ar-
rest, resulting in an increase of polyploid cells from 24% to150 Cell Reports 15, 147–157, April 5, 201638% (Figure 3D). These data suggest
that ORC2mut cells were temporally ar-
rested at the G2 phase; however, these
cells could bypass mitosis and endoredu-
plicate their genome to become tetra-
ploidy/polyploid cells.
Aberrant Centromeric Histone H3
Methylation in ORC2 SUMOylation
Mutant Cells
ORC2 has been shown to localize at the
centromeric chromatin at the G2/M phase
(Craig et al., 2003; Prasanth et al., 2004).
We found that ORC2 mutant cells have amarked increase in H3K4me3 and 50% reduction in H3K4me2
in the centromeric chromatin, as compared to the ORC2wt cells
(Figures 4A and S4A–S4C), whereas abundance of H3K4me2
and H3K4me3 on whole chromosomes or at the non-centromere
gene promoter of NUSAP1 is equal in both cells (Figures S4D and
S4E). Alterations of the H3K4 methylation at centromeric chro-
matin have been shown to associate with reduced abundance
of CENP-A and abnormal non-coding RNA transcription from
a-satellite DNA (Bergmann et al., 2011). Indeed, the amount of
centromeric CENP-A was reduced by about 20% in ORC2mut
cells (Figure 4B), and a-satellite RNA transcripts were 50%
less in ORC2mut cells than in ORC2wt cells (Figure 4C). These
non-coding RNA transcripts are crucial for maintaining pericen-
tric a-satellite heterochromatin silencing (Fukagawa et al., 2004;
Schueler and Sullivan, 2006; Zhu et al., 2011). Accordingly,
pericentric a-satellite heterochromatin marker H3K9me2 was
markedly reduced in ORC2mut cells (Figures 4D and S4F).
Furthermore, ORC2mut cells showed loss of compaction of the
chromosome 19 satellite repeat by DNA fluorescent in situ hy-
bridization (FISH) (Prasanth et al., 2010) (Figure S4G). Other het-
erochromatin markers, H3K9me3 and H4K20me3, were also
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Figure 4. A Defect of ORC2 SUMOylation
Results in Formation of Polyploidy
(A) ORC2wt and ORC2mut cells were released into
fresh media for 18 hr after 24 hr treatment with
mimosine. The G2 phase cells with 4C DNA con-
tents were sorted, and the relative occupancy of
H3, H3K4me2, and H3K4me3 within a-satellite
of chromosome 1 was analyzed using ChIP-PCR.
The data represent the means and SEM of three
independent experiments.
(B) ORC2wt and ORC2mut cells were treated as
in (A). The G2 phase cells with 4C DNA contents
were sorted, and the relative occupancy of CENP-A
within a-satellite of chromosome 1 was analyzed
using ChIP-PCR. The data represent the means
and SEM of three independent experiments.
(C) ORC2wt and ORC2mut cells were treated as in
(A). The G2 phase cells with 4C DNA contents were
sorted, and the transcription of chromosome 1
a-satellite DNA was analyzed by real-time PCR.
The data were normalized to beta-actin and shown
as folds of ORC2wt. The data represent the means
and SEM of three independent experiments.
(D) ORC2wt and ORC2mut cells were treated as in
(A). The G2 phase cells with 4C DNA contents were
sorted, and the relative occupancy of H3K9me2
within a-satellite of chromosome 1 was analyzed
using ChIP-PCR. The data represent the means
and SEM of three independent experiments.
(E) ORC2wt and ORC2mut cells were treated as in
(A). The G2 phase cells with 4C DNA contents were
sorted, and the relative occupancy of H3K9me3
within the region of Sat2 was analyzed using ChIP-
PCR. The data represent the means and SEM of
three independent experiments.
See also Figures S4 and S5.decreased at the pericentric satellite 2 (Sat2) region of chromo-
some 2 and 10, leading to increased transcription of Sat2
DNA (Figures 4E, S4H, and S4I). Aberrant histone H3 and H4
methylation at the a-Sat and Sat2 region in ORC2 SUMOylation
mutant cells was not due to change of ORC2 localization, as
SUMOylation did not alter ORC2 localization in centromeric
chromatin (Figures S4J and S4K). To investigate whether de-
regulated CEN histone H3 methylation causes the abnormal
cell cycle profiles, we transiently transfected U2OS cells to ex-
press wild-type or mutated FLAG-ORC2 (K36 and 51R) (Fig-
ure S5A). Cell cycle profiles and histone H3K4 methylation at
a-satellite chromatin were analyzed by FACS and ChIP assay
(Figures S5B and S5C). The results showed that deregulated
H3K4 methylation at centromeric chromatin caused formation
of polyploidy in FLAG-ORC2 (K36 and 51R) transfected cells.
Taken together, these results suggest that pericentric hetero-
chromatin condensation is impaired in ORC2mut cells.
Failure to Modify ORC2 with SUMO2 Results in
Pericentric Heterochromatin DNA Re-replication
Loss of chromatin condensation at the pericentric heterochro-
matin promotes DNA re-replication (Black et al., 2013; Jacob
et al., 2010). Indeed, 5-ethynyl-20-deoxyuridine (EdU) incorpora-
tion assay showed an increase in DNA replication activity mainly
at the centromere region (defined with anti-CENP-A staining) inthe ORC2mut, but not ORC2wt cells (Figure 5A). Consistently,
the copy numbers of centromere DNA were increased in the
ORC2mut cells compared with ORC2wt cells (Figure 5B). As
DNA re-replication at the G2 phase activates DNA damage
checkpoint and eventually arrest cells at the G2 phase (Klotz-
Noack et al., 2012), we investigated whether DNA damage
response (DDR) could be observed in the ORC2mut cells. As
shown in Figures 5C and 5D, gH2AX as well as phosphorylation
of Chk1 and Chk2 were increased in the ORC2mut cells, but not
in the ORC2wt cells. Importantly, the sites of gH2AX colocalized
with CENP-A (Figure 5C). To determine whether DDR was
directly responsible for the G2 arrest and endoreduplication in
ORC2mut cells, cell cycle profiles were analyzed in the ORC2wt
or ORC2mut cells, which were treated with caffeine, a DNA
damage checkpoint inhibitor, for 24 hr. The cell population with
DNA content >4C was significantly reduced from 16.1% to 7%
in caffeine-treated ORC2mut cells (Figure 5E), whereas there
was no significant change in ORC2wt cells. These data suggest
that SUMO2 modification of ORC2 is important in preventing
pericentric heterochromatin DNA re-replication at the G2 phase.
SUMO2 Modification of ORC2 Promotes Recruitment of
KDM5A to Centromere
ORC2mut cells exhibit a marked increase in H3K4me3 and
reduction in H3K4me2 at centromeric chromatin. This could beCell Reports 15, 147–157, April 5, 2016 151
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Figure 5. SUMOylation of ORC2 Enhances
the Recruitment of KDM5A to Centromeric
Chromatin
(A) ORC2wt and ORC2mut cells were released into
fresh media for 18 hr after 24 hr treatment with
mimosine and then cells were labeled with EdU
(green) for 15 min. The co-immunostaining was
performed with anti-CENP-A (red) antibody. The
cells with 2CDNA content are shown. The scale bar
represents 10 mM.
(B) ORC2wt and ORC2mut cells with 2C DNA
content were sorted by FACS and then were
treated with mimosine for 24 hr and released into
freshmedia for 18 hr. An equal number of cells were
used to isolate genomic DNA for real-time PCR.
Mimosine arrested cells as control. The y axis
represents the ratio of the intensity of PCR prod-
ucts in ORC2mut cells to that in ORC2wt cells. The
x axis indicates the primers used for PCR (lamin B2,
Lam; telomere, Tel; and centromere, Cen).
(C) ORC2wt and ORC2mut cells were treated as in
(A). The cells were co-immunostained with anti-g-
H2AX antibody (green) and anti-CENP-A antibody
(red). The nuclei were co-stained with DAPI (blue).
Merged pictures are shown. The scale bar repre-
sents 10 mM.
(D) ORC2wt and ORC2mut cells were treated as in
(A). The cells were lysed and immunoblotted with
the indicated antibodies.
(E) ORC2wt and ORC2mut cells were treated with
caffeine for 24 hr and then subjected to FACS. The
cell cycle profiles and percentage of cell population
with >4C DNA content was shown.due to reduction of H3K4me3 demethylases in the centromere.
Thus, we asked whether ORC2 could recruit H3K4 demethylase
to the centromere. Interestingly, ORC2 could co-precipitate with
KDM5A, but not KDM5B or KDM5C (Figure 6A). Furthermore,
the ORC2 SUMOylation mutant precipitated much less KDM5A
than that of ORC2wt cells in the G2 phase, suggesting that
SUMOylation enhances binding of ORC2 to KDM5A (Figure 6B).
ORC2 in the G2 cells also interacted with more KDM5A than in
asynchronous cells (Figure S6A). To directly demonstrate a
role for SUMO2 modification of ORC2 in binding to KDM5A,
we performed a binding assay using purified FLAG-KDM5A
to pull down SUMOylated GST-ORC2 or unmodified GST-
ORC2. As shown in Figure 6C, KDM5A could pull down both
SUMOylated and un-SUMOylated ORC2 proteins, however,
the binding efficiency to SUMO2-modified ORC2 was 4-fold
higher than that of unmodified ORC2, indicating that SUMO2
enhances ORC2 binding to KDM5A (Figure 6C). We then used
ChIP assay to further confirm that SUMOylation of ORC2 could
promote recruitment of KDM5A to the centromere. ChIP assay152 Cell Reports 15, 147–157, April 5, 2016with anti-KDM5A antibody showed that
enrichment of KDM5A was significantly
reduced at the a-satellite chromatin of
ORC2mut cells in comparison with that
of ORC2wt cells (Figure 6D), whereas
recruitment of KDM5A to its non-centro-
mere target gene promoter of NUSAP1was not affected in ORC2mut cells, suggesting specific
KDM5A recruitment to centromere by SUMOylated ORC2 (Lo-
pez-Bigas et al., 2008) (Figure S6B). Reduced recruitment of
KDM5A to centromere is not due to additional effect on ORC2
protein structure by mutation, but due to a loss of SUMOylation
of ORC2, as overexpression of de-SUMOylase SENP2 also
caused less recruitment of KDM5A to centromere (Figures S6C
and S6D). To further elucidate the mechanism, we tested
whether KDM5A interacts with SUMO2 in vitro. GST pull-down
assay showed that GST-SUMO2, but not GST, could pull
down endogenous KDM5A (Figure 6E). As KDM5A contains
several highly conserved SUMO interaction motifs (SIM), we
hypothesized that binding of KDM5A to SUMO2 was SIM-
dependent. We showed that the interaction of FLAG-KDM5A
and SUMO2 was perturbed by increasing concentration of a
SIM peptide, which contains short amino acid sequences
corresponding to conserved SIM of PIAS2 (Bruderer et al.,
2011), indicating that SUMO2 enhances ORC2 binding to
KDM5A through a SIM-dependent mechanism (Figure S6E). By
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Figure 6. Centromeric DNA Re-replication
in ORC2 SUMOylation Mutant—K36 and
51R—Cells
(A) Differential binding capacities of ORC2 with
members of KDM5 family. Asynchronous U2OS
cells were fractionated and chromatin was sub-
jected to immunoprecipitation with the ORC2
antibody. The immunoprecipitates were blotted
with the indicated antibodies.
(B) ORC2wt and ORC2mut cells were released
into fresh media for 18 hr after 24 hr treat-
ment with mimosine. The cells were frac-
tionated and chromatin was subjected to
immunoprecipitation with the FLAG antibody.
The immunoprecipitates were blotted with the
anti-FLAG or anti-KDM5A antibody. The densi-
tometry analysis shows the binding capacity
of FLAG-ORC2wt or FLAG-ORC2mut with
KDM5A.
(C) GST-ORC2 protein was first SUMOylated
in vitro and then a mixture of SUMO2-conju-
gated or unconjugated ORC2 was incubated
with FLAG-KDM5A protein that was pulled
down from U2OS cells transfected with FLAG-
KDM5A. The immunoprecipitation was per-
formed with the anti-FLAG antibody, and
precipitates were immunoblotted with the anti-
FLAG, anti-GST, or anti-SUMO2 antibody. The
densitometry analysis shows the binding ca-
pacity of ORC2 or SUMOylated ORC2 with
KDM5A.
(D) ORC2wt and ORC2mut cells were released
into fresh media for 18 hr after 24 hr treatment
with mimosine. The G2 phase cells with 4C DNA
contents were sorted, and the relative occupancy
of KDM5A within the region of a-satellite was
analyzed using ChIP-PCR. The data represent the
means and SEM of three independent experi-
ments.
(E) KDM5A protein pulled down from U2OS cells
was incubated with GST or GST-SUMO2 protein.
After incubation, glutathione beads were added
and incubated for 30 min. The precipitates were
immunoblotted with anti-GST antibody or anti-
KDM5A antibody.
(F) U2OS cells were transfected with KDM5A
siRNA and were released into fresh media for 18 hr
after 24 hr treatment with mimosine. The immunostaining was performed as in Figure 5A. The scale bar represents 10 mM.
(G) U2OS cells were transfected with KDM5A shRNA, and the cell cycle was analyzed using FACS.
(H) ORC2wt and ORC2mut cells were transient transfected with FLAG-ORC2wt or HA-KDM5A as indicated, the percentage of cells in the cell cycle were re-
corded by FACS.
See also Figure S6.combining GPS-SBM program prediction and site-directed
mutagenesis, we identified VLDL (1588–1591) sequence of
KDM5A as a potential SIM (Figure S6F).
To further elucidate the mechanism, KDM5A was knocked
down in the cells (Figure S6G). We showed that incorporation
of EdU was readily detected at the centromeric chromatin of
KDM5A-silenced G2 phase U2OS cells in comparison to control
cells (Figure 6F). a-satellite transcription was impaired in KDM5A
knockdown cells (Figure S6H). FACS analysis of KDM5A-
silenced U2OS cells showed a marked increase in 4C and >4C
cells similar to the profile of ORC2 mutant cells (Figures 6G
and S6I). Finally, re-expression of ORC2wt cells greatly reduced>4C population in ORC2mut cells, whereas expression of
KDM5A reduced >4C cells to a lesser extent (Figure 6H).
DISCUSSION
In this study, we showed that ORC2 was specifically conjugated
by SUMO2 at the G2/M phase of the cell cycle. Inhibition of
ORC2 SUMOylation resulted in abnormal mitosis and formation
of polyploidy. Mechanistically, SUMOylation promotes ORC2
recruitment of a H3K4me3 demethylase KDM5A to centromere
at the G2/M phase to convert H3K4me3 to H3K4me2, a permis-
sive histone marker for the transcription of non-coding RNACell Reports 15, 147–157, April 5, 2016 153
from a-satellite. These a-satellite transcripts were essential for
maintaining pericentric heterochromatin to prevent DNA re-repli-
cation and chromatin instability. Our results reveal a mechanism
whereby SUMOylation regulates centromeric histone modifica-
tion to maintain genomic stability in cells.
It is well known that ORC2 is a component of the pre-RC com-
plex, which initiates DNA replication at early S phase in mamma-
lian cells (Bell and Dutta, 2002). However, ORC2 is not required
for DNA replication initiation once pre-RC is formed (Shimada
et al., 2002). ORC2 gradually dissociates from DNA replication
origins and localizes to centromere in the G2/M phase (Lee
et al., 2012; Prasanth et al., 2004). Depletion of ORC2 resulted
in mitotic arrest due to defects in chromosome condensation
(Prasanth et al., 2004). In yeast, ORC2 is required for sister-
chromatid cohesion. Downregulation of ORC2 leads to the cell
cycle arrested at the G2/M phase (Shimada and Gasser, 2007).
The Drosophila ORC2 mutant k43 also causes G2/M phase
arrest with abnormally condensed chromosomes (Pflumm and
Botchan, 2001). These studies indicate a critical role of ORC2
in regulation of chromosome condensation at the G2/M phase.
However, how ORC2 regulates chromosome condensation at
the G2/M phase is not known. In this study, we showed that
ORC2 is SUMOylated at the G2/M phase. SUMOylation is
crucial for ORC2 recruitment of KDM5A to the centromere to
maintain normal centromeric histone H3 methylation. Failure to
SUMOylate ORC2 or silencing of KDM5A causes DNA re-repli-
cation and chromosome instability at the G2/M phase.
Reduced heterochromatin marks H3K9me2/3 can lead
to impaired pericentric heterochromatin condensation and
increased non-coding RNA transcripts from pericentric a-satel-
lite heterochromatin (Peters et al., 2001;Wang et al., 2013). How-
ever, Bergmann et al. (2011) reported that reduced H3K4me2
occupation at CEN chromatin also results in reduced a-satellite
transcription. Therefore, transcription of a-satellite DNA is most
probably regulated by bothH3K4 andH3K9methylation at a-sat-
ellite chromatin. We detected a decrease in a-satellite DNA tran-
scription that may result from both deregulated H3K4me2/3 and
H3K9me2 at centromeric a-satellite chromatin in ORC2mut cells.
It hasbeen reported thatperturbationof histoneH3methylation in
the pericentric heterochromatin can result in partial DNA re-repli-
cation (Black et al., 2013; Jacob et al., 2010). Overexpression of
KDM4A, aH3K9/36me3 demethylase, could decreaseH3K9me3
and increase re-replication at chromosome 1 Sat2 region (Black
et al., 2010, 2013). Mutation in H3K27 monomethyltransferases
ATXR5 and ATXR6 in Arabidopsis also causes re-replication of
specific heterochromatin (Jacob et al., 2010). Importantly, bind-
ing to unmethylated H3K27 by ATXR5 and ATXR6 is strongly
affected by tri-methylated H3K4, suggesting H3K4me3 play
a role in heterochromatin DNA re-replication control (Jacob
et al., 2010). Our data demonstrate that KDM5A, a H3K4me2/3
demethylase, is important in preventing heterochromatin DNA
re-replication by controllingH3K4methylation at CEN chromatin.
KDM5A has demethylation activity on both of H3K4me3 and
H3K4me2 in vitro, but prefers H3K4me3 in vivo (Christensen
et al., 2007; Klose et al., 2007). Recently, it was shown that
KDM5A preferentially binds to promoter regions that are enriched
with H3K4me3. Silencing of KDM5A leads to 5–20 times increase
in H3K4me3 level at some gene promoters, whereas the level of154 Cell Reports 15, 147–157, April 5, 2016H3K4me2 is only marginally affected (Beshiri et al., 2012). Our re-
sults showed that reduced recruitment of KDM5A to the centro-
mere of the G2/M cells causes an accumulation of H3K4me3 at
the CEN chromatin in ORC2 SUMOylation mutant cells, suggest-
ing that ORC2 SUMOylation is important in recruiting KDM5A in
the centromere. Analysis of hematopoietic stem cell (HSC) and
myeloid progenitor from KDM5A/ mice showed an increased
proportion of cells entering the S/G2/M phase of the cell cycle
(Klose et al., 2007). Although no obvious difference in KDM5A
expression level in ORC2wt and ORC2mut cells was observed,
however,KDM5Abinding tocentromere issignificantlydecreased
in ORC2mut cells. This leads to abnormality of chromatin behav-
iors at the G2/M phase and formation of polyploidy, a hallmark
of malignant transformation (Storchova and Kuffer, 2008).
DNA re-replication can cause DDR and arrest cells at the
G2/M phase (Davidson et al., 2006; Gillis et al., 2009; Janss
et al., 2001; Klotz-Noack et al., 2012). However, prolonged
G2/M arrest can result in bypass of mitosis and endoreduplica-
tion of genome, leading to formation of polyploidy (Brito
and Rieder, 2006; Davoli et al., 2010). We show that DNA re-
replication at centromeric region causes DDR in the G2 ORC2
SUMOylation mutant cells. DDR would in turn temporarily arrest
cells at the G2 phase and degrade cyclin A and cyclin B, leading
to bypass of mitosis and eventually endoreduplication of
genome and formation of polyploidy.
In summary, our data show that SUMOylation of ORC2 is
crucial for normal pericentric heterochromatin condensation
and chromosome segregation at the G2/M phase. This is
achieved by SUMOylation of ORC2, which promotes the
recruitment of demethylase KDM5A to centromere to maintain
H3K4me2 modification and a-satellite DNA transcription (Fig-
ure 7). However, histone modification in the centromeres could
also be regulated by other mechanisms.EXPERIMENTAL PROCEDURES
Construction of Plasmids
For transit transfection, the full-length cDNAs of ORC2 and KDM5A were
cloned into 3 3 FLAG (Sigma) vector, respectively, by using standard proce-
dures (Dou et al., 2010). For generating stable cells, FLAG-ORC2 fragment
was PCR amplified from 3 3 FLAG vector and sub-cloned into PQCXIP
vector (Clontech). This plasmid was then transfected into Platinum A cells
for production of retrovirus particles, which were used for generating stable
cells. Site-specificmutationwas introduced using aQuikChange Site-Directed
Mutagenesis Kit (Agilent).
Cell Culture and Generation of Cells Continuously Expressing
FLAG-ORC2wt or FLAG-ORC2: K36 and 51R
U2OS cells (ATCC) were grown under standard tissue-culture conditions. To
generate U2OS cells continuously expressing FLAG-ORC2wt (ORC2wt cells)
or FLAG-ORC2 (K36, 51R) (ORC2mut cells), PQCXIP vectors containing
FLAG-ORC2wt or FLAG-ORC2mut fragment were first transfected into
Platinum A package cells (Cell Biolabs) using Fugene 6 transfection reagent
(Roche). At 2 days after transfection, the supernatant was collected and
filtered through a 0.45 mm filter. Medium (1 ml) was removed from a 3-cm plate
with the U2OS cells at around 40%–50% confluence and 1ml of filtered super-
natant was added with polybrene (final polybrene concentration, 8 mg/ml).
U2OS cells were selected by puromycin (0.5 mg/ml) after 24 hr infection.
ORC2wt and ORC2mut U2OS cells stably expressing GFP-H2B were gener-
ated by transfection with GFP-H2B and selected with puromycin (0.5 mg/ml)
and neomycin (200 mg/ml).
AB
Figure 7. Role of ORC2 SUMOylation inMain-
taining Genomic Stability
(A) ORC2 SUMOylation in the G2/M phase recruits
demethylase KDM5A to centromere to maintain
a normal level of H3K4me2, which is crucial for
condensation of pericentric heterochromatin.
(B) Loss of ORC2 SUMOylation in the G2/M phase
cannot recruit demethylase KDM5A to centromere,
which leads to accumulation of H3K4me3 and
decondensation of pericentric heterochromatin.For synchronization experiments, ORC2wt and ORC2mut cells were syn-
chronized either to the late G1 phase using 0.5mM mimosine (Sigma) for
24 hr or to the G2/M phase using 50 ng/ml nocodazole for 24 hr (Sigma).
FACS
FACS analysis for DNA content was performed using standard methods and
PI DNA staining. Flow cytometry was performed using FACS caliber (Becton
Dickinson), and FlowJo software was used for estimation of the percentage
of cells in various phases of the cell cycle.
Immunofluorescence
For FLAG-ORC2 staining, cultured ORC2wt and ORC2mut cells were either
stained with FLAG antibody or treated with mimosine for 24 hr and released
into fresh medium for 18 hr and then cells were pretreated with CSK buffer
and fixed as described (Prasanth et al., 2004). For g-H2AX and CENP-A co-
staining, ORC2wt and ORC2mut cells were treated with mimosine for 24 hr
and released into fresh medium for 18 hr, cells were treated and processed
as described previously (Dou et al., 2010). Antibody staining was performed
as follows: primary antibodies were anti-g-H2AX (cat. #05-636-I, Millipore),
anti-FLAG (cat. #F1804, Sigma), anti-CENP-A (cat. #2186, Cell Signaling),
and anti-pericentrin (cat. #ab4448, Abcam). After incubation with the primaryantibodies at room temperature for 1 hr, Alexa 488-
and Alexa 594-labeled secondary antibodies (Life
Technology) were added for 1 hr. Cells were then
adhered to a slide with DAPI-staining Mounting
Medium (Vector Labs). For EdU staining, the Click-
iT EdU Alexa Fluor 488 Imaging Kit (Life Technology)
was used according to the manufacturer’s protocol.
Chromatin fiber immunostaining was performed
essentially as described previously (Blower et al.,
2002). In brief, 104 cell/ml in 75 mM KCl were centri-
fugedontochargedmicroscopeslides (Fisher Scien-
tific) and lysing in salt detergent buffer supplemented
with urea for 15 min before slowly removing and
fixing in 4% paraformaldehyde (PFA). Slides were
incubated in 1 3 PBST (1 3 PBS + 0.05% Tween-
20) and blocked in 1 3 PBS, 1% BSA, and 0.1%
Triton X-100 for 30 min at room temperature before
incubation with appropriate primary, then second-
ary, antibodies diluted in blocking buffer. All samples
were visualized with an Olympus fluorescence mi-
croscope and images were derived with the accom-
panying DP-BSW application software program.
DNA FISH
DNA FISH were performed as described (Prasanth
et al., 2010). ORC2wt and ORC2mut cells were
pre-extracted in cytoskeletal buffer (CSK: 100 mM
NaCl, 300 mM sucrose, 3 mM MgCl2, and 10 mM
PIPES at pH 6.8) containing 0.5% Triton X-100 for
5 min on ice and fixed with 3.7% freshly prepared
formaldehyde for 15 min at room temperature. The
cells were washed in 1 3 PBS (pH 7.2) and heatdenatured in 70% formamide and 2 3 saline sodium citrate (SSC) at 72C
for 5 min followed by hybridization with labeled chromosome 19-specific
satellite probe (Agilent) in 2 3 SSC, 50% formamide, 10% dextran sulfate,
yeast tRNA, and Cot-1 DNA overnight at 37C.
Cell Fractionation, Immunoprecipitation, and Talon Beads
Pull-Down
Cell fractionation was performed as described previously (Me´ndez and
Stillman, 2000). Chromatin of U2OS cells was sonicated and digested with
0.2 U micrococcal nuclease (Sigma). Supernatant was used for routine
immunoprecipitation and western blotting with anti-ORC2 (cat. #4736, Cell
Signaling), anti-FLAG (Sigma), anti-KDM5A (cat. #A300-897A, Bethyl lab),
anti-KDM5B (cat. #3273), and anti-KDM5C (cat. #5361) (Cell Signaling)
antibodies. Talon beads pull-down was performed as described previously
(Huang et al., 2009). For DDR marker, anti-Chk1 (cat. #sc-8408), anti-Chk2
(cat. #sc-9064) (Santa Cruz), anti-pChk1 (cat. #2344), and anti-pChk2 (cat.
#2661) (Cell Signaling) antibodies were used.
Genomic DNA PCR
ORC2wt and ORC2mut cells were sorted and 2N cells were treated with mim-
osine for 24 hr and released into fresh media for 18 hr. Genomic DNA wasCell Reports 15, 147–157, April 5, 2016 155
extracted for real-time PCR. Primers used are described previously (Zhu et al.,
2004).
Real-Time RT-PCR
Total RNA was extracted using TRIzol (Life Technology) and precipitated with
ethanol. To exclude potential contamination of DNA, RNA was treated by
DNase I for 30 min at 37C and then reversed to cDNA using the Advantage
RT-for-PCR Kit (Clontech). The relative expression of Sat2 and a-Sat was
measured using real-time PCR with SYBR-green dye. Primers for chromo-
some 1 a-satellite DNA were purchased from Cell Signaling. Primers for
Sat2 DNA (Wang et al., 2013), forward: CATCGAATGGAAATGAAAGGAGTC
and reverse: ACCATTGGATGATTGCAGTCAA.
ChIP Assay
Chromatin-IP was performed using the ChIP Assay Kit (Millipore) according to
the manufacturer’s protocol by using anti-H3 (cat. #14269), anti-CENP-A (Cell
Signaling), anti-FLAG (Sigma), anti-KDM5A (Bethyl lab), anti-H3K4me2 (cat.
#9725, Cell Signaling), anti-H3K4me3 (cat. #8580), anti-H3K9me2 (cat. #1220),
anti-H3K9me3 (cat. #8898), and anti-H4K20me3 (cat. #9053) (Abcam). Real-
time PCR was performed to detect relative occupancy with the same primers
used in the real-time PCR assay. ChIP experiment for NUSAP1 gene promoter
was performed according to a previous report (Lopez-Bigas et al., 2008).
In Vitro SUMOylation Assay
0.5 mg of GST-ORC2 (Novus) was used for the assay using the SUMOlink
SUMO-2/3 Kit (Active Motif), according to the manufacturer’s protocol.
In Vitro Binding Assay
GST or GST-SUMO2 fusion protein (0.2 mg) was used for the direct binding
assay as described previously (Dou et al., 2010). For the binding assay be-
tween SUMOylated ORC2 and FLAG-KDM5A, 0.5 mg of GST-ORC2 was first
conjugated by SUMO2 in vitro and amixture of SUMO2 conjugated- or uncon-
jugated GST-ORC2 was incubated with FLAG-KDM5A pulled down from cells
transfected with FLAG-KDM5A in 500 ml of binding buffer (50 mM Tris-HCl
[pH 7.9], 200 mM NaCl, 1 mM EDTA, 1% Triton X-100, and 1 mM DTT) for
1 hr at 4C, anti-FLAG beads were added for 1 hr. Precipitates were washed
four times, and proteins were eluted using SDS-PAGE loading buffer and sub-
jected to immunoblotting.
Metaphase Chromosome Spread
ORC2wt and ORC2mut cells were used for the assay. The experiments were
performed and the percentage of various cell defects was calculated by
Molecular Cytogenetics Core Facility, The University of Texas MD Anderson
Cancer Center, Houston, Texas.
siRNA
RNA Oligonucleotides for KDM5A (GGAUGAACAUUCUGCCGAATT) were
purchased from Life Technology. KDM5A lentiviral shRNA were purchased
from Thermo Scientific. Transfection of siRNA was performed as described
previously (Dou et al., 2010).
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